Well they most definitely do need regular checks on production. But maybe there is some way to do this while avoiding the patent - Sanofi is proof that this is possible.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.